Physician profile
Carl Humphrey
NPI 1811978778
$9,417,752.22
in general payments reported to CMS, 2019-2025
11 companies · $1.8M in 2025
The $1.8M reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1.1M · 2020: $962K · 2021: $1.2M · 2022: $1.3M · 2023: $1.5M · 2024: $1.6M · 2025: $1.8M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $4.9M · Consulting Fee: $60K · Travel and Lodging: $3,604 · Food and Beverage: $1,515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $4,872,161.37 |
| Consulting Fee | $60,450.16 |
| Travel and Lodging | $3,604.04 |
| Food and Beverage | $1,514.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, Lp | $9,379,891.88 | 2019-2025 | Djo Surgical |
| Uoc USA INC | $36,378.54 | 2019-2025 | System One, Tru Axis, System One Shoulder |
| Djo, LLC | $630.45 | 2019 | |
| Steelhead Surgical INC | $147.50 | 2021-2024 | |
| Shoulder Innovations, INC. | $144.87 | 2025 | Inset System |
| Stryker Corporation | $113.46 | 2023 | Aequalis Flex Revive, Aequalis Perform Reversed, Blueprint Patient Specific Instrumentation |
| Exactech, INC. | $105.34 | 2023 | |
| Smith+Nephew, INC. | $101.73 | 2024 | Aetos Shoulder System, Twinfix |
| Medical Device Business Services, INC. | $84.33 | 2025 | |
| Zimmer Biomet Holdings, INC. | $79.12 | 2025 | |
| Arthrex, INC. | $75.00 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carl Humphrey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.